Showing results (221-230 of 933) with videos related to
Sort By:
Pageof 94
Clinical Lymphoma & Myeloma|March 27, 2007
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challengesElias Jabbour, Jorge Cortes, Susan O'Brien, et al.Expert Review of Anticancer Therapy|March 13, 2015
The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemiaDavid S Sanford, Hagop Kantarjian, Susan O'Brien, et al.Current Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.Human Pathology|October 21, 2018
Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual eventKuixing Zhang, Daniel Farrell, Deepa Jeyakumar, et al.Cancer|March 13, 2010
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrenceStefan Faderl, Alessandra Ferrajoli, William Wierda, et al.Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory PatientsAnna Maria Frustaci, Alessandra Tedeschi, Alexander F Vom Stein, et al.Cancer|April 14, 2007
Current and emerging treatment options in chronic myeloid leukemiaElias Jabbour, Jorge E Cortes, Francis J Giles, et al.Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.Clinical Lymphoma, Myeloma & Leukemia|July 16, 2024
Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic LeukemiaJulie S Braish, Eitan Kugler, Elias Jabbour, et al.Pageof 94